Pfizer's Avastin biosimilar wins FDA approval
Pfizer Inc said on Friday that the U.S. Food and Drug Administration had approved its biosimilar to Roche Holding AG's blockbuster cancer treatment Avastin.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tqT4cNvCHTRQTzUybQaGjjbUXM2J3m4GPe9FscbxqSQEuLzmeAc4MrFzKappuKhpKG6xJJOjBqvFpfO_ZJjhd6iU6Vg-W4n9fqa_qyaVoq4aVYS2u2mmzqvSwTbHuJHx9dmVw=s0-d)
from Reuters: Health News https://ift.tt/2RKjkll
from Reuters: Health News https://ift.tt/2RKjkll
Comments
Post a Comment